186 related articles for article (PubMed ID: 36142575)
1. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma.
Ferrara B; Dugnani E; Sordi V; Pasquale V; Pellegrini S; Reni M; Balzano G; Piemonti L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142575
[TBL] [Abstract][Full Text] [Related]
2. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
[TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
[TBL] [Abstract][Full Text] [Related]
5. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.
Mortoglou M; Miralles F; Arisan ED; Dart A; Jurcevic S; Lange S; Uysal-Onganer P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163198
[TBL] [Abstract][Full Text] [Related]
6. Primary and Metastatic Pancreatic Cancer Cells Exhibit Differential Migratory Potentials.
Park JK; Hank T; Scherber CM; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Toner M; Irimia D; Thayer SP; Liss AS
Pancreas; 2020 Jan; 49(1):128-134. PubMed ID: 31856088
[TBL] [Abstract][Full Text] [Related]
7. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
[TBL] [Abstract][Full Text] [Related]
8. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
[TBL] [Abstract][Full Text] [Related]
10. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.
Zhu J; He J; Liu Y; Simeone DM; Lubman DM
J Proteome Res; 2012 Apr; 11(4):2272-81. PubMed ID: 22335271
[TBL] [Abstract][Full Text] [Related]
11. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
12. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.
Han J; Fujisawa T; Husain SR; Puri RK
BMC Cancer; 2014 Mar; 14():173. PubMed ID: 24612587
[TBL] [Abstract][Full Text] [Related]
14. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
Sahlberg SH; Spiegelberg D; Glimelius B; Stenerlöw B; Nestor M
PLoS One; 2014; 9(4):e94621. PubMed ID: 24760019
[TBL] [Abstract][Full Text] [Related]
16. Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.
Huang P; Wang CY; Gou SM; Wu HS; Liu T; Xiong JX
World J Gastroenterol; 2008 Jun; 14(24):3903-7. PubMed ID: 18609717
[TBL] [Abstract][Full Text] [Related]
17. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
[TBL] [Abstract][Full Text] [Related]
18. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.
Roudi R; Madjd Z; Ebrahimi M; Samani FS; Samadikuchaksaraei A
Cell Mol Biol Lett; 2014 Mar; 19(1):23-36. PubMed ID: 24363164
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
20. Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma.
Skoda J; Hermanova M; Loja T; Nemec P; Neradil J; Karasek P; Veselska R
PLoS One; 2016; 11(7):e0159255. PubMed ID: 27414409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]